Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02963493
Title A Study of Melflufen in Combination With Dexamethasone in Relapsed Refractory Multiple Myeloma Patients (HORIZON)
Acronym HORIZON
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oncopeptides AB
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP

Facility Status City State Zip Country Details
Innovative Clinical Research Institute (ICRI) Whittier California 90603 United States Details
University of Florida Gainesville Florida 32610 United States Details
RUSH Chicago Illinois 60612 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Karmanos Cancer Center Detroit Michigan 48201 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Hudson Valley Hematology Oncology Poughkeepsie New York 10532 United States Details
UPMC Hillman Cancer Insitute Pittsburgh Pennsylvania 15232 United States Details
Baylor Dallas Texas 75246 United States Details
CHU de Nantes Nantes 44000 France Details
CHU de Poitiers Poitiers 86021 France Details
Universita di Bolognia Bologna 40126 Italy Details
Turin Hospital Myeloma Unit Turin 10126 Italy Details
Hospital Clinic i Provincial de Barcelona Barcelona 08036 Spain Details
Institut Català d'Oncología (ICO) Badalona Barcelona 08916 Spain Details
Hospital Universitario de La Princesa Madrid 28006 Spain Details
Hospital Universitario Fundación Jiménez Díaz Madrid 28040 Spain Details
Clínica Universidad de Navarra Pamplona 31008 Spain Details
Complejo Hospitalario de Salamanca Salamanca 37007 Spain Details
Hospital Universitario Doctor Peset Valencia 46017 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field